Tamotsu Takeuchi Selected Research

H-cadherin (T-cadherin)

4/2017	Adiponectin and Intelectin-1: Important Adipokine Players in Obesity-Related Colorectal Carcinogenesis.
2/2010	T-cadherin modulates tumor-associated molecules in gallbladder cancer cells.
1/2009	Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer.
9/2007	Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease.
3/2006	An adiponectin receptor, T-cadherin, was selectively expressed in intratumoral capillary endothelial cells in hepatocellular carcinoma: possible cross talk between T-cadherin and FGF-2 pathways.
12/2002	Downregulation of expression of a novel cadherin molecule, T-cadherin, in basal cell carcinoma of the skin.
8/2002	Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma.
6/2002	Expression of T-cadherin in Basal keratinocytes of skin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tamotsu Takeuchi Research Topics

Disease

33	Neoplasms (Cancer) 01/2021 - 05/2002
13	Carcinogenesis 04/2021 - 09/2003
6	Adenocarcinoma 01/2021 - 09/2003
5	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2003
5	Neoplasm Metastasis (Metastasis) 06/2019 - 12/2002
4	Signet Ring Cell Carcinoma 11/2019 - 03/2012
4	Gallbladder Neoplasms (Gallbladder Cancer) 12/2012 - 01/2009
4	Leukemia 12/2009 - 06/2006
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2006 - 01/2003
4	Adenocarcinoma of Lung 06/2006 - 06/2004
3	Stomach Neoplasms (Stomach Cancer) 04/2021 - 01/2021
3	Squamous Cell Carcinoma of Head and Neck 01/2021 - 04/2019
3	Clear Cell Sarcoma 06/2019 - 06/2014
3	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2015
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2018 - 01/2014
3	Synovial Sarcoma (Synovioma) 01/2018 - 02/2002
3	Melanoma (Melanoma, Malignant) 02/2014 - 06/2002
3	Prostatic Neoplasms (Prostate Cancer) 06/2006 - 10/2004
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 03/2007
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2018
2	Cardiotoxicity 10/2018 - 06/2017
2	Lymphatic Metastasis 01/2018 - 01/2015
2	T-Cell Lymphoma (Lymphoma, T Cell) 12/2017 - 01/2013
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 12/2017 - 06/2017
2	Lymphoma (Lymphomas) 10/2017 - 01/2013
2	Neurofibrosarcoma (MPNST) 12/2015 - 05/2013
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2014 - 12/2009
2	Basal Cell Carcinoma (Rodent Ulcer) 05/2014 - 12/2002
2	Lymphadenopathy 07/2012 - 04/2009
2	Hepatocellular Carcinoma (Hepatoma) 01/2011 - 03/2006
2	Lung Neoplasms (Lung Cancer) 01/2007 - 06/2004
1	Ovarian Neoplasms (Ovarian Cancer) 02/2022
1	Cleft Lip (Harelip) 01/2021
1	Cleft Palate (Palate, Cleft) 04/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2018
1	Residual Neoplasm 01/2018
1	Necrosis 01/2018
1	Inflammation (Inflammations) 10/2017

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 04/2021 - 02/2002
8	AntibodiesIBA 04/2021 - 06/2006
8	H-cadherin (T-cadherin)IBA 04/2017 - 06/2002
7	Small Interfering RNA (siRNA)IBA 03/2021 - 03/2007
6	Messenger RNA (mRNA)IBA 04/2021 - 01/2006
6	matrigelIBA 01/2021 - 04/2011
6	Biological ProductsIBA 04/2019 - 12/2002
6	Carbonic Anhydrases (Carbonic Anhydrase)IBA 03/2007 - 01/2003
4	AdiponectinIBA 01/2021 - 09/2007
3	LigandsIBA 04/2021 - 06/2005
3	AntigensIBA 01/2021 - 06/2006
3	Monoclonal AntibodiesIBA 01/2021 - 09/2003
3	WW Domain-Containing OxidoreductaseIBA 01/2021 - 01/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2018 - 06/2017
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2018 - 06/2017
3	Prednisolone (Predate)FDA LinkGeneric 10/2018 - 06/2017
3	pirarubicinIBA 10/2018 - 06/2017
3	Vincristine (Oncovin)FDA LinkGeneric 10/2018 - 06/2017
3	UbiquitinIBA 02/2014 - 05/2005
3	Ligases (Synthetase)IBA 02/2014 - 05/2005
3	CollagenIBA 03/2012 - 01/2009
2	Peptides (Polypeptides)IBA 04/2021 - 01/2007
2	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 04/2021 - 01/2019
2	devimistatIBA 03/2021 - 01/2018
2	Rituximab (Mabthera)FDA Link 10/2018 - 09/2017
2	Methotrexate (Mexate)FDA LinkGeneric 09/2017 - 01/2013
2	Codon (Codons)IBA 11/2013 - 05/2002
2	AgarIBA 05/2013 - 10/2004
2	Matrix Metalloproteinases (MMPs)IBA 09/2011 - 04/2011
2	Capsules (Microcapsules)IBA 12/2007 - 11/2006
2	Adiponectin ReceptorsIBA 09/2007 - 03/2006
2	AndrogensIBA 06/2006 - 10/2004
2	Human immunodeficiency virus 1 p16 proteaseIBA 07/2005 - 10/2004
2	Caspase 3 (Caspase-3)IBA 10/2004 - 06/2004
2	Cadherins (E-Cadherin)IBA 12/2002 - 06/2002
1	Annexin A2 (Annexin II)IBA 01/2021
1	CarbohydratesIBA 01/2021
1	Butyric Acid (Butanoic Acid)IBA 01/2021
1	ElementsIBA 01/2021
1	EpitopesIBA 01/2021
1	Laminin ReceptorsIBA 10/2019
1	Laminin (Merosin)IBA 10/2019
1	Cisplatin (Platino)FDA LinkGeneric 04/2019
1	Doxycycline (Periostat)FDA LinkGeneric 01/2019
1	Alcian BlueIBA 01/2019
1	SynaptophysinIBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	Phenobarbital (Luminal)FDA Link 01/2019
1	Chloroquine (Aralen)FDA LinkGeneric 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	ParaffinIBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2017
1	KynurenineIBA 12/2017

Therapy/Procedure

5	Therapeutics 01/2021 - 10/2004
2	VAP-cyclo protocol 06/2017 - 01/2014
2	Boron Neutron Capture Therapy 12/2015 - 06/2014
2	Immunotherapy 01/2007 - 06/2006
1	Ovariectomy (Oophorectomy) 02/2022
1	Appendectomy 02/2022
1	Transplantation 06/2019
1	Cystectomy 01/2018